' Акцијски курс '

Datum	Sight Sciences Cena akcije
5. 9. 2024.	6,41 undefined
4. 9. 2024.	6,41 undefined
3. 9. 2024.	6,29 undefined
30. 8. 2024.	6,77 undefined
29. 8. 2024.	6,76 undefined
28. 8. 2024.	6,72 undefined
27. 8. 2024.	6,81 undefined
26. 8. 2024.	7,05 undefined
23. 8. 2024.	6,76 undefined
22. 8. 2024.	6,32 undefined
21. 8. 2024.	6,37 undefined
20. 8. 2024.	6,08 undefined
19. 8. 2024.	6,38 undefined
16. 8. 2024.	6,05 undefined
15. 8. 2024.	6,03 undefined
14. 8. 2024.	5,79 undefined
13. 8. 2024.	5,95 undefined
12. 8. 2024.	5,79 undefined
9. 8. 2024.	5,96 undefined
8. 8. 2024.	5,83 undefined

Datum	Sight Sciences Promet	Sight Sciences EBIT	Sight Sciences Profit
2026e	105,40 mil. undefined	-24,64 mil. undefined	-25,85 mil. undefined
2025e	93,57 mil. undefined	-41,61 mil. undefined	-37,38 mil. undefined
2024e	84,00 mil. undefined	-49,07 mil. undefined	-47,95 mil. undefined
2023	81,06 mil. undefined	-57,27 mil. undefined	-55,55 mil. undefined
2022	71,33 mil. undefined	-83,95 mil. undefined	-86,24 mil. undefined
2021	48,96 mil. undefined	-51,48 mil. undefined	-62,96 mil. undefined
2020	27,64 mil. undefined	-32,19 mil. undefined	-34,69 mil. undefined
2019	23,35 mil. undefined	-24,04 mil. undefined	-25,87 mil. undefined
2018	7,53 mil. undefined	-14,30 mil. undefined	-14,29 mil. undefined

	Promet	EBIT	Profit
2018	7,53 mil. USD	-14,30 mil. USD	-14,29 mil. USD
2019	23,35 mil. USD	-24,04 mil. USD	-25,87 mil. USD
2020	27,64 mil. USD	-32,19 mil. USD	-34,69 mil. USD
2021	48,96 mil. USD	-51,48 mil. USD	-62,96 mil. USD
2022	71,33 mil. USD	-83,95 mil. USD	-86,24 mil. USD
2023	81,06 mil. USD	-57,27 mil. USD	-55,55 mil. USD
2024e	84,00 mil. USD	-49,07 mil. USD	-47,95 mil. USD
2025e	93,57 mil. USD	-41,61 mil. USD	-37,38 mil. USD
2026e	105,40 mil. USD	-24,64 mil. USD	-25,85 mil. USD

2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
7,00	23,00	27,00	48,00	71,00	81,00	83,00	93,00	105,00
-	228,57	17,39	77,78	47,92	14,08	2,47	12,05	12,90
71,43	69,57	66,67	83,33	81,69	85,19	-	-	-
5,00	16,00	18,00	40,00	58,00	69,00	0	0	0
-14,00	-24,00	-32,00	-51,00	-83,00	-57,00	-49,00	-41,00	-24,00
-200,00	-104,35	-118,52	-106,25	-116,90	-70,37	-59,04	-44,09	-22,86
-14,00	-25,00	-34,00	-62,00	-86,00	-55,00	-47,00	-37,00	-25,00
-	78,57	36,00	82,35	38,71	-36,05	-14,55	-21,28	-32,43
45,06	45,06	45,06	26,73	47,85	48,63	0	0	0
-	-	-	-	-	-	-	-	-

2018	2019	2020	2021	2022	2023

4,20	21,20	61,50	260,70	185,00	138,13
1,80	4,10	5,40	8,70	15,10	14,29
0	0	0	0	0	0
0,50	2,20	2,60	3,50	6,10	7,85
0,60	0,40	1,20	4,20	3,40	2,60
7,10	27,90	70,70	277,10	209,60	162,87
0,90	2,60	1,80	2,90	3,20	3,10
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
100,00	200,00	400,00	200,00	200,00	682,00
1,00	2,80	2,20	3,10	3,40	3,78
8,10	30,70	72,90	280,20	213,00	166,65

34,20	64,30	117,30	0	0	0,05
0,50	0,70	1,20	385,10	399,30	414,96
-29,50	-55,30	-90,00	-153,00	-239,20	-294,79
0	0	0	0	0	0
0	0	0	0	0	0
5,20	9,70	28,50	232,10	160,10	120,21
1,90	2,30	2,20	3,40	2,70	1,73
1,00	5,00	7,20	10,20	15,10	8,30
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	2,22
2,90	7,30	9,40	13,60	17,80	12,25
0	12,90	32,00	32,70	33,30	31,71
0	0	0	0	0	0
0	1,00	3,10	1,90	1,90	2,48
0	13,90	35,10	34,60	35,20	34,18
2,90	21,20	44,50	48,20	53,00	46,44
8,10	30,90	73,00	280,30	213,10	166,65

2018	2019	2020	2021	2022	2023
-14,00	-25,00	-34,00	-62,00	-86,00	-55,00
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	-4,00	-5,00	-9,00
0	1,00	1,00	19,00	28,00	31,00
0	0	0	3,00	3,00	4,00
0	0	0	0	0	0
-14,00	-25,00	-32,00	-52,00	-75,00	-47,00
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	14,00	20,00	0	0	0
12,00	30,00	53,00	257,00	1,00	1,00
12,00	42,00	73,00	252,00	1,00	1,00
-	-2,00	-	-4,00	-	-
0	0	0	0	0	0
-2,00	16,00	40,00	199,00	-75,00	-46,00
-15,05	-25,67	-33,12	-53,35	-76,94	-47,98
0	0	0	0	0	0

Sight Sciences Bruto marža	Sight Sciences Profitna marža	Sight Sciences EBIT marža	Sight Sciences Profitna marža
2026e	85,34 %	-23,37 %	-24,53 %
2025e	85,34 %	-44,47 %	-39,95 %
2024e	85,34 %	-58,42 %	-57,09 %
2023	85,34 %	-70,66 %	-68,53 %
2022	82,67 %	-117,69 %	-120,90 %
2021	82,41 %	-105,15 %	-128,59 %
2020	66,68 %	-116,46 %	-125,51 %
2019	71,95 %	-102,96 %	-110,79 %
2018	68,92 %	-189,91 %	-189,77 %

	Bruto marža	EBIT marža	Profitna marža
2018	68,92 %	-189,91 %	-189,77 %
2019	71,95 %	-102,96 %	-110,79 %
2020	66,68 %	-116,46 %	-125,51 %
2021	82,41 %	-105,15 %	-128,59 %
2022	82,67 %	-117,69 %	-120,90 %
2023	85,34 %	-70,66 %	-68,53 %
2024e	85,34 %	-58,42 %	-57,09 %
2025e	85,34 %	-44,47 %	-39,95 %
2026e	85,34 %	-23,37 %	-24,53 %

Datum	Sight Sciences Prihod po akciji	Sight Sciences EBIT po akciji	Sight Sciences Dobit po akciji
2026e	2,10 undefined	0 undefined	-0,51 undefined
2025e	1,86 undefined	0 undefined	-0,74 undefined
2024e	1,67 undefined	0 undefined	-0,95 undefined
2023	1,67 undefined	-1,18 undefined	-1,14 undefined
2022	1,49 undefined	-1,75 undefined	-1,80 undefined
2021	1,83 undefined	-1,93 undefined	-2,36 undefined
2020	0,61 undefined	-0,71 undefined	-0,77 undefined
2019	0,52 undefined	-0,53 undefined	-0,57 undefined
2018	0,17 undefined	-0,32 undefined	-0,32 undefined

	Prihod po akciji	EBIT po akciji	Dobit po akciji
2018	0,17 USD	-0,32 USD	-0,32 USD
2019	0,52 USD	-0,53 USD	-0,57 USD
2020	0,61 USD	-0,71 USD	-0,77 USD
2021	1,83 USD	-1,93 USD	-2,36 USD
2022	1,49 USD	-1,75 USD	-1,80 USD
2023	1,67 USD	-1,18 USD	-1,14 USD
2024e	1,67 USD	0 USD	-0,95 USD
2025e	1,86 USD	0 USD	-0,74 USD
2026e	2,10 USD	0 USD	-0,51 USD

	Broj akcija
2018	45,06 mil. Aktien
2019	45,06 mil. Aktien
2020	45,06 mil. Aktien
2021	26,73 mil. Aktien
2022	47,85 mil. Aktien
2023	48,63 mil. Aktien
2024e	48,63 mil. Aktien
2025e	48,63 mil. Aktien
2026e	48,63 mil. Aktien

Datum	Procena EPSa	EPS-Actual	Kvartal izveštaja
30. 6. 2024.	-0,30	-0,25 (17,19 %)	2024 Q2
31. 3. 2024.	-0,28	-0,33 (-17,35 %)	2024 Q1
31. 12. 2023.	-0,32	-0,22 (31,95 %)	2023 Q4
30. 9. 2023.	-0,32	-0,27 (16,72 %)	2023 Q3
30. 6. 2023.	-0,35	-0,30 (13,87 %)	2023 Q2
31. 3. 2023.	-0,40	-0,35 (12,50 %)	2023 Q1
31. 12. 2022.	-0,43	-0,35 (17,71 %)	2022 Q4
30. 9. 2022.	-0,47	-0,46 (1,56 %)	2022 Q3
30. 6. 2022.	-0,43	-0,50 (-15,98 %)	2022 Q2
31. 3. 2022.	-0,41	-0,49 (-19,86 %)	2022 Q1
31. 12. 2021.	-0,40	-0,34 (14,85 %)	2021 Q4
30. 9. 2021.	-0,38	-0,43 (-14,67 %)	2021 Q3
30. 6. 2021.	-1,76	-1,83 (-4,01 %)	2021 Q2

%	Ime	Акције	Promena	Datum
9,24 %	KCK, Ltd.	4.646.866	0	31. 12. 2023.
7,99 %	Allegro Investment, Inc.	4.022.118	-632.456	30. 11. 2023.
6,31 %	BofA Global Research (US)	3.174.134	3.094.315	31. 12. 2023.
5,76 %	UBS Financial Services, Inc.	2.895.958	2.881.750	31. 12. 2023.
4,34 %	Encrantz (Staffan)	2.181.314	1.602.478	30. 11. 2023.
3,45 %	Badawi (David)	1.735.468	-3.128	3. 4. 2024.
3,24 %	Jackson Square Partners, LLC	1.629.746	174.737	31. 12. 2023.
2,93 %	The Vanguard Group, Inc.	1.474.682	72.778	31. 12. 2023.
2,72 %	BlackRock Institutional Trust Company, N.A.	1.368.652	-42.958	31. 12. 2023.
2,02 %	JP Morgan Asset Management	1.015.380	50.751	31. 12. 2023.
11,19 %	Badawi (Paul)	5.631.205	-12.571	3. 4. 2024.
1,49 %	Link (Matthew W)	747.572	747.572	14. 11. 2023.
1,33 %	Apollo Capital Management, L.P.	671.520	0	31. 12. 2023.
1,12 %	Geode Capital Management, L.L.C.	565.091	34.793	31. 12. 2023.
0,88 %	State Street Global Advisors (US)	441.644	-171.679	31. 12. 2023.
0,80 %	D. E. Shaw & Co., L.P.	404.835	142.142	31. 12. 2023.
0,60 %	Jacobs Levy Equity Management, Inc.	300.508	300.508	31. 12. 2023.
0,46 %	Park Sam Boong	229.640	-3.414	3. 4. 2024.
0,39 %	Hayden (Jeremy Bragg)	197.119	-4.893	3. 4. 2024.
0,39 %	Charles Schwab Investment Management, Inc.	196.956	-29.478	31. 12. 2023.
0,38 %	Point72 Asset Management, L.P.	193.001	27.923	31. 12. 2023.
0,38 %	Selnick (Jesse)	190.209	25.209	4. 1. 2023.
0,37 %	Northern Trust Investments, Inc.	184.583	-6.620	31. 12. 2023.
0,35 %	Hicks (Mack H)	175.986	89.780	31. 12. 2022.
0,35 %	Palo Alto Investors LP	173.790	173.790	31. 12. 2023.
0,33 %	RTW Investments L.P.	164.806	164.806	31. 12. 2023.
0,29 %	Squarepoint Capital LLP	144.663	24.575	31. 12. 2023.
0,25 %	BMO Capital Markets (US)	123.500	123.500	31. 12. 2023.
0,24 %	Bridgeway Capital Management, LLC	121.400	121.400	31. 12. 2023.
0,20 %	JPMorgan Private Bank (United States)	102.253	18.139	31. 12. 2023.
0,17 %	Susquehanna International Group, LLP	85.903	85.903	31. 12. 2023.
0,17 %	Dimensional Fund Advisors, L.P.	83.866	-12.945	31. 12. 2023.
0,16 %	Acadian Asset Management LLC	78.415	78.415	31. 12. 2023.
0,15 %	Renaissance Technologies LLC	77.400	11.400	31. 12. 2023.
0,15 %	Morgan Stanley Smith Barney LLC	75.831	28.648	31. 12. 2023.
0,14 %	Jane Street Capital, L.L.C.	70.536	70.536	31. 12. 2023.
0,13 %	Morgan Stanley & Co. LLC	63.885	35.895	31. 12. 2023.
0,12 %	PanAgora Asset Management Inc.	59.190	39.333	31. 12. 2023.
0,12 %	BNY Mellon Asset Management	58.493	-42.582	31. 12. 2023.
0,11 %	Parametric Portfolio Associates LLC	57.039	-27.343	31. 12. 2023.
0,11 %	BlackRock Investment Management, LLC	56.651	-469	31. 12. 2023.
0,10 %	Millennium Management LLC	49.719	-139.552	31. 12. 2023.
0,09 %	Marshall Wace LLP	47.513	47.513	31. 12. 2023.
0,09 %	BlackRock Financial Management, Inc.	45.693	-21.204	31. 12. 2023.
0,08 %	Concurrent Investment Advisors, LLC	42.252	42.252	31. 12. 2023.
0,08 %	State Teachers Retirement System of Ohio	41.100	0	31. 12. 2023.
0,07 %	Voya Investment Management LLC	36.001	36.001	31. 12. 2023.
0,06 %	Larsen-Becker (Brenda Jane)	30.722	15.094	8. 6. 2023.
0,06 %	IBK Asset Management Co., Ltd.	30.288	-2.148	30. 9. 2023.
0,06 %	Mazzacco (Catherine)	30.189	30.189	8. 6. 2023.
0,06 %	Barclays Bank PLC	29.725	20.081	31. 12. 2023.
0,06 %	Rhumbline Advisers Ltd. Partnership	27.822	0	31. 12. 2023.
0,05 %	Zurbay (Donald J)	27.034	27.034	8. 6. 2023.
0,05 %	Rogers (Erica J.)	27.034	27.034	8. 6. 2023.
0,05 %	American Century Investment Management, Inc.	24.934	9.026	31. 12. 2023.
0,05 %	Avantis Investors	23.855	2.487	31. 3. 2024.
0,04 %	Balyasny Asset Management LP	22.639	22.639	31. 12. 2023.
0,04 %	Rodberg (James)	21.299	20.600	16. 3. 2023.
0,04 %	AllianceBernstein L.P.	20.450	0	31. 12. 2023.
0,03 %	Mirae Asset Global Investments (USA) LLC	17.547	-8.787	31. 12. 2023.
0,03 %	Fountain (Tamara R.)	15.094	15.094	8. 6. 2023.
0,03 %	State Street Global Advisors Ireland Limited	14.459	-53	30. 4. 2023.
0,03 %	XTX Markets LLC	14.115	14.115	31. 12. 2023.
0,03 %	Wolverine Trading, LLC	14.019	14.019	31. 12. 2023.
0,03 %	Northern Trust Global Investments	13.756	-3.595	31. 12. 2023.
0,02 %	Tower Research Capital LLC	12.076	7.764	31. 12. 2023.
0,02 %	Sygnia Asset Management	11.974	11.974	30. 9. 2023.
0,02 %	Schroeder (Valeska)	11.940	11.940	8. 6. 2023.
0,02 %	AQR Capital Management, LLC	10.950	10.950	31. 12. 2023.
0,02 %	SunAmerica Asset Management, LLC	10.742	-43	31. 12. 2023.
0,02 %	Prelude Capital Management, LLC	10.355	-6.200	31. 12. 2023.
0,02 %	Lazard Asset Management, L.L.C.	9.782	9.782	31. 12. 2023.
0,02 %	Dimensional Fund Advisors, Ltd.	9.425	0	31. 1. 2024.
0,02 %	DWS Investments UK Limited	9.271	9.271	31. 3. 2024.
0,02 %	Signaturefd, LLC	8.433	0	31. 12. 2023.
0,02 %	RBC Capital Markets Wealth Management	8.129	-7.021	31. 12. 2023.
0,01 %	Fidelity Management & Research Company LLC	7.439	3.876	31. 12. 2023.
0,01 %	Mellon Investments Corporation	6.505	-2	31. 12. 2023.
0,01 %	Becker (Brenda)	5.974	-11.949	11. 4. 2023.
0,01 %	Legal & General Investment Management Ltd.	5.754	-10.031	31. 12. 2023.
0,01 %	Wells Fargo Bank, N.A.	5.670	1.279	31. 12. 2023.
0,01 %	UBS Asset Management (Americas), Inc.	5.600	5.600	31. 12. 2023.
0,01 %	CIBC Asset Management Inc.	5.300	0	31. 12. 2023.
0,01 %	Champlain Investment Partners, LLC	5.200	5.200	31. 12. 2023.
0,01 %	U.S. Bancorp Asset Management, Inc.	5.200	5.200	31. 12. 2023.
0,01 %	RBC Wealth Management, International	4.610	1.904	31. 12. 2023.
0,01 %	Manulife Investment Management (North America) Limited	4.291	0	31. 1. 2024.
0,01 %	Mine & Arao Wealth Creation & Management, LLC	4.068	0	31. 12. 2023.
0,01 %	ProShare Advisors LLC	3.883	716	31. 3. 2024.
0,01 %	Simplex Trading, LLC	3.636	3.636	31. 12. 2023.
0,01 %	California State Teachers Retirement System	3.557	-29.026	31. 12. 2023.
0,01 %	Citi Investment Research (US)	3.278	3.137	31. 12. 2023.
0,01 %	Credit Suisse Asset Management (Schweiz) AG	3.162	3.162	30. 9. 2023.
0,01 %	Amalgamated Bank Institutional Asset Management & Custody	3.086	-225	31. 12. 2023.
0,01 %	Principal Global Investors (Equity)	2.717	0	29. 2. 2024.
0,00 %	Huntington Private Financial Group	2.500	0	31. 12. 2023.
0,00 %	New York State Common Retirement Fund	2.413	0	31. 12. 2023.
0,00 %	Mackenzie Financial Corporation	2.389	-1.214	31. 12. 2023.
0,00 %	DFA Australia Ltd.	2.150	4	31. 12. 2023.
0,00 %	Caldwell Sutter Capital, Inc	2.000	0	31. 3. 2024.

What values and corporate philosophy does Sight Sciences represent?

Sight Sciences Inc represents a commitment to innovation, patient care, and improved healthcare outcomes. With a focus on developing cutting-edge medical devices and therapies, the company aims to enhance the lives of individuals suffering from eye diseases by providing effective treatment options. Sight Sciences Inc places great importance on advancing medical technology to address unmet needs and improve the quality of ophthalmic care. Through a patient-centered approach and dedication to research and development, Sight Sciences Inc is dedicated to making a positive impact in the field of ophthalmology while prioritizing the well-being of patients.

In which countries and regions is Sight Sciences primarily present?

Sight Sciences Inc is primarily present in the United States.

What significant milestones has the company Sight Sciences achieved?

Sight Sciences Inc has achieved several significant milestones. Firstly, the company successfully developed and commercialized innovative medical devices focused on eye health, such as the OMNI Surgical System and TearCare System. These technologies offer effective and minimally invasive solutions for glaucoma and dry eye disease. Additionally, Sight Sciences Inc received various regulatory approvals, including FDA clearances, reinforcing the safety and efficacy of their products. The company has also established strategic partnerships and collaborations with renowned ophthalmologists and institutions worldwide, fostering advancements in eye care. These milestones indicate Sight Sciences Inc's commitment to revolutionizing the field of ophthalmology and improving patients' quality of life.

What is the history and background of the company Sight Sciences?

Sight Sciences Inc. is a renowned company specializing in the development of innovative medical devices and technologies. Established in [insert year], Sight Sciences has been at the forefront of transforming ophthalmic care. With its visionary approach, the company aims to revolutionize the treatment of ocular conditions, particularly glaucoma and dry eye disease. Sight Sciences Inc. is committed to providing state-of-the-art solutions to enhance patient outcomes and improve quality of life. Having gained significant recognition in the medical industry, Sight Sciences continues to lead the way in delivering groundbreaking advancements that address the unmet needs of patients worldwide.

Who are the main competitors of Sight Sciences in the market?

The main competitors of Sight Sciences Inc in the market include companies such as Glaukos Corporation, Ivantis Inc, and Allergan Plc.

In which industries is Sight Sciences primarily active?

Sight Sciences Inc is primarily active in the medical technology industry.

What is the business model of Sight Sciences?

The business model of Sight Sciences Inc revolves around developing and commercializing innovative and minimally invasive medical devices for eye care professionals. The company aims to address unmet needs in the field of ophthalmology by providing advanced technologies that enhance patient outcomes. Sight Sciences Inc focuses on two primary areas: glaucoma and dry eye disease. By offering cutting-edge technologies like the OMNI Surgical System and TearCare, the company enables eye care professionals to diagnose, treat, and manage these conditions effectively. Sight Sciences Inc's business model is driven by its commitment to improving patient lives through the development of advanced medical devices for ophthalmic use.

Koji P/E odnos ima Sight Sciences 2024?

P/E odnos Sight Sciences iznosi -6,50.

Koji je KUV za Sight Sciences 2024?

KUV kompanije Sight Sciences iznosi 3,71.

Koji AlleAktien kvalitetni skor ima Sight Sciences?

AlleAktien kvalitativni skor za Sight Sciences je 3/10.

Koliki je prihod od Sight Sciences 2024?

očekivana Sight Sciences promet je 84,00 mil. USD.

Koliki je profit kompanije Sight Sciences 2024?

Dobit očekivana Sight Sciences je -47,95 mil. USD.

Шта ради Sight Sciences?

Sight Sciences Inc is an innovative medical technology company specializing in the development of advanced medical devices for the treatment of eye diseases. The company was founded in 2011 and is headquartered in Menlo Park, California. Sight Sciences has developed a wide range of products tailored to the needs of ophthalmologists, optometrists, and patients. Their portfolio includes three main products: OMNI Surgical System, TearCare, and TRAB 360. OMNI Surgical System is a unique medical device used to treat various eye diseases. The system effectively lowers intraocular pressure by expanding the eye's natural drainage pathways. OMNI is a versatile system that can be used for different procedures such as canaloplasty or trabeculotomy. TearCare is another product from Sight Sciences used to treat dryness and other tear disorders. The device is easy to use and provides effective operation and quick results. It uses heat to open the glands in the eyelids and stimulate tear production. The third main product from Sight Sciences is TRAB 360, a device specifically designed for the treatment of glaucoma. The device can be used in combination with a surgical procedure to lower intraocular pressure and slow down the progression of the disease. Sight Sciences is committed to improving eye health worldwide. The company has focused on developing devices that can be easily and effectively used by physicians. Additionally, there is a focus on developing devices that are able to improve the quality of life for patients. Sight Sciences' business model is based on selling medical products to ophthalmologists and optometrists. As a company, Sight Sciences strives to develop new and innovative solutions for the treatment of eye diseases. The company keeps customer needs in mind and works closely with leading ophthalmologists to develop products that meet patient needs. Overall, Sight Sciences Inc has built a successful business model. The company has proven its ability to develop innovative products that provide real value to ophthalmologists and patients. With a diverse product portfolio and advanced technologies, Sight Sciences will continue to play an important role in the medical technology industry.

Kolika je Sight Sciences dividenda?

Sight Sciences isplaćuje dividendu od 0 USD raspoređenu preko isplata u toku godine.

Koliko često Sight Sciences isplaćuje dividendu?

Dividenda za Sight Sciences trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

Šta je Sight Sciences ISIN?

ISIN od Sight Sciences je US82657M1053.

Koji je Sight Sciences berzanski simbol?

Oznaka za praćenje akcija kompanije Sight Sciences je SGHT.

Kolika je dividenda koju isplaćuje Sight Sciences?

U poslednjih 12 meseci, Sight Sciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Sight Sciences će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Sight Sciences?

Dividendski prinos od Sight Sciences trenutno iznosi .

Kada Sight Sciences isplaćuje dividendu?

Sight Sciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Sight Sciences?

Sight Sciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Sight Sciences?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Sight Sciences?

Sight Sciences se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Sight Sciences kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Sight Sciences od 6. 9. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 6. 9. 2024..

Kada je Sight Sciences poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 6. 9. 2024..

Kolika je bila dividenda od Sight Sciences u godini 2023?

U godini 2023 kompanija Sight Sciences je isplatila 0 USD kao dividende.

U kojoj valuti Sight Sciences isplaćuje dividendu?

Dividende od Sight Sciences se isplaćuju u USD.

Direktne emisije	—
Indirektne emisije iz kupljene energije	—
Indirektne emisije unutar lanca vrednosti	—
CO₂ emisije	—
Strategija redukcije CO₂	✅
Ugalj energija	❌
Atomska energija	❌
Eksperimenti na životinjama	❌
Pelz & Leder	—
Pesticidi	—
Palmino ulje	—
Tabak	❌
Gentechnika	❌
Koncept klime	—
Održivo šumarstvo	—
Pravila o reciklaži	❌
Ekološka ambalaža	❌
Opasne materije	❌
Potrošnja i efikasnost goriva	❌
Potrošnja i efikasnost vode	❌

Udeo žena zaposlenih	—
Udeo žena u menadžmentu	—
Udeo azijskih zaposlenih	—
Udeo azijskog menadžmenta	—
Udeo hispansko/latinskih zaposlenih	—
Udeo hispano/latino menadžmenta	—
Udeo crnačkih zaposlenih	—
Udeo crnačkog menadžmenta	—
Udeo belih zaposlenih	—
Udeo belačkog menadžmenta	—
Sadržaji za odrasle	❌
Alkohol	❌
Odbrana	—
oružje	❌
Kockanje	❌
Ugovori o vojsci	❌
Koncept ljudskih prava	❌
Koncept zaštite podataka	—
Zaštita na radu i zdravlje	✅
Katolički	✅

Izveštaj o održivosti	❌
Angažovanje zainteresovanih strana	❌
Politika povlačenja	❌
Antimonopolsko pravo	❌

Sight Sciences Тикер	Sight Sciences FIGI
SGHT:US	BBG006BZHZC7
SGHT:UA	BBG011KQ69S0
SGHT:UC	BBG011KQ69T9
SGHT:UN	BBG011KQ69W5
SGHT:UP	BBG011KQ69X4
SGHT:UB	BBG011KQ69Z2
SGHT:UM	BBG011KQ6B14
SGHT:UX	BBG011KQ6B23
SGHT:UD	BBG011KQ6B78
SGHT:UW	BBG011KQ6B96
SGHT:UF	BBG011KQ6BB3
SGHT:VY	BBG011KQ6BC2
SGHT:VJ	BBG011KQ6BD1
SGHT:VK	BBG011KQ6BF9
SGHT:VF	BBG011KQ6BG8

Napravi najbolje investicije svog života. fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cena

Cena

ТикерSGHT

ISINUS82657M1053

Sight Sciences Cena akcije

Kurs

Pregled

Intraday funkcija

Ukupan prinos i relativna promena cene

Interpretacija i investiranje

Sight Sciences Istorija kursa

Sight Sciences Akcija Promet, EBIT, Dobit US82657M1053 ·

Promet, Profit & EBIT

Razumevanje prometa, EBIT-a i prihoda

Godišnja analiza i poređenja

Koristite očekivanja za investiranje

Uvid u investicije

Sight Sciences Prihod, dobit i EBIT istorija

Sight Sciences Akcija Kennzahlen

GuV

Prihod i rast

Bruto marža

EBIT i EBIT marža

Prihod i rast

Izdate akcije

Interpretacija godišnje usporedbe

Očekivanja i prognoze

Bilans

Razumevanje bilansa

Sredstva

Obaveze

Kapital

Analiza iz godine u godinu

Interpretacija podataka

Sight Sciences Акција Маргине US82657M1053 ·

Margine

Razumevanje bruto marže

Analiza marže EBIT

Uvidi u maržu obrta

Tumačenje očekivanja

Analiza poređenja

Sight Sciences Istorija margine

Sight Sciences акција промет, EBIT, добит по акцији US82657M1053 ·

Promet, EBIT i Zarada po deonici

Promet po deonici

EBIT po deonici

Prihod po deonici

Očekivane vrednosti

Sight Sciences Promet, dobit i EBIT po akciji - istorija

Sight Sciences Akcija i analiza akcija

Sight Sciences Оцена према Fair Value

Fair Value

Razumevanje Fair Value

Fair Value zasnovan na dobitku

Fair Value zasnovan na prihodu

Fair Value zasnovan na dividendi

Očekivanja i prognoze

Uporedna analiza

Sight Sciences Ocena na osnovu istorijskog KGV, EBIT i KUV

Sight Sciences Broj akcija US82657M1053 ·

Promet, EBIT i Zarada po deonici

Promet po deonici

EBIT po deonici

Prihod po deonici

Očekivane vrednosti

Sight Sciences Procene zarade

Sight Sciences Iznenađenja u zaradi

Eulerpool ESG ocena za akciju Sight Sciences

Eulerpool World ESG Rating (EESG©)

45/ 100

🌱 Environment

👫 Social

🏛️ Governance

Životna sredina (Environment)

Društveno (Social)

Upravljanje preduzećem (Governance)

Sight Sciences Akcija Struktura vlasništva

Sight Sciences Upravni i Nadzorni odbor

Česta pitanja o Sight Sciences akciji

Napravi najbolje investicije svog života.
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Тикер
SGHT

ISIN
US82657M1053